(Q53635286)

English

Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. (English)

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

cutaneous lymphoma

1 reference

based on heuristic

inferred from title

British Association of Dermatologists

5

object named as

British Association of Dermatologists

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

author name string

S J Whittaker

1

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

J R Marsden

2

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

M Spittle

3

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

R Russell Jones

4

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

U.K. Cutaneous Lymphoma Group

6

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

British Journal of Dermatology

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

149

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

1095-1107

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

6

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05698.X

21 January 2018

Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05698.X

21 January 2018

Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05698.X

21 January 2018

Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05698.X

21 January 2018

Topical corticosteroids for mycosis fungoides. Experience in 79 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05698.X

21 January 2018

A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05698.X

21 January 2018

Narrowband TL-01 phototherapy for patch-stage mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05698.X

21 January 2018

Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05698.X

21 January 2018

Pegylated doxorubicin for primary cutaneous T-cell lymphoma: a report on ten patients with follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05698.X

21 January 2018

T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05698.X

21 January 2018

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05698.X

21 January 2018

Extracorporeal photopheresis in Sézary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05698.X

21 January 2018

Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05698.X

21 January 2018

Detection of a Peripheral Blood T Cell Clone is an Independent Prognostic Marker in Mycosis Fungoides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05698.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2003.05698.X

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/14696593

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53635286&oldid=1525336756"